Emp6_2.part06.rar

Research related to "EMP6_2.part06.rar" points to studies identifying m6Am to the sixth power cap A

RNA methylation-regulated prognostic signatures in cancers such as lung adenocarcinoma. These studies typically establish high- and low-risk patient groups based on molecular signatures to predict survival outcomes and immune infiltration patterns. Read the full study on m6A-regulated signatures at PMC9593055 . EMP6_2.part06.rar